FR2100797A1 - - Google Patents

Info

Publication number
FR2100797A1
FR2100797A1 FR7122334A FR7122334A FR2100797A1 FR 2100797 A1 FR2100797 A1 FR 2100797A1 FR 7122334 A FR7122334 A FR 7122334A FR 7122334 A FR7122334 A FR 7122334A FR 2100797 A1 FR2100797 A1 FR 2100797A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7122334A
Other languages
French (fr)
Other versions
FR2100797B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2100797A1 publication Critical patent/FR2100797A1/fr
Application granted granted Critical
Publication of FR2100797B1 publication Critical patent/FR2100797B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
FR7122334A 1970-06-19 1971-06-18 Expired FR2100797B1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH931870A CH547802A (de) 1970-06-19 1970-06-19 Verfahren zur herstellung von tetrahydropyridinderivaten.

Publications (2)

Publication Number Publication Date
FR2100797A1 true FR2100797A1 (de) 1972-03-24
FR2100797B1 FR2100797B1 (de) 1974-08-23

Family

ID=4350687

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7122334A Expired FR2100797B1 (de) 1970-06-19 1971-06-18

Country Status (16)

Country Link
AT (5) AT309428B (de)
BE (1) BE768689A (de)
CA (1) CA984844A (de)
CH (1) CH547802A (de)
DE (1) DE2128836A1 (de)
DK (1) DK132887C (de)
ES (1) ES392388A1 (de)
FR (1) FR2100797B1 (de)
GB (5) GB1338058A (de)
HU (1) HU162417B (de)
IE (1) IE35369B1 (de)
IL (1) IL36827A (de)
NL (1) NL7108416A (de)
NO (1) NO133548C (de)
SE (1) SE378814B (de)
ZA (1) ZA713032B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2501689A1 (fr) * 1981-03-16 1982-09-17 Bristol Myers Co N-((4-phenyl-1,2,3,6-tetrahydropyridine-1-yl)alkylene)azaspiroalcanediones, composition pharmaceutique les contenant, et n-((4-hydroxy-4-phenylpiperidine-1-yl)alkylene) azaspiroalcanediones intermediaires permettant de les obtenir

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4985074A (de) * 1972-12-22 1974-08-15
AU717140B2 (en) * 1996-03-08 2000-03-16 F. Hoffmann-La Roche Ag Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives as NMDA receptor subtype blockers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2027037A1 (de) * 1968-12-24 1970-09-25 Hoffmann La Roche

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2027037A1 (de) * 1968-12-24 1970-09-25 Hoffmann La Roche

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2501689A1 (fr) * 1981-03-16 1982-09-17 Bristol Myers Co N-((4-phenyl-1,2,3,6-tetrahydropyridine-1-yl)alkylene)azaspiroalcanediones, composition pharmaceutique les contenant, et n-((4-hydroxy-4-phenylpiperidine-1-yl)alkylene) azaspiroalcanediones intermediaires permettant de les obtenir

Also Published As

Publication number Publication date
NL7108416A (de) 1971-12-21
AT309428B (de) 1973-08-27
GB1338059A (en) 1973-11-21
FR2100797B1 (de) 1974-08-23
CH547802A (de) 1974-04-11
DK132887B (da) 1976-02-23
CA984844A (en) 1976-03-02
SE378814B (de) 1975-09-15
ES392388A1 (es) 1973-08-01
GB1338060A (en) 1973-11-21
DE2128836A1 (de) 1971-12-23
AT309432B (de) 1973-08-27
HU162417B (de) 1973-02-28
ZA713032B (en) 1972-01-26
GB1338058A (en) 1973-11-21
DK132887C (da) 1976-07-26
AT309431B (de) 1973-08-27
IE35369B1 (en) 1976-01-21
IL36827A0 (en) 1971-07-28
AT309433B (de) 1973-08-27
AT311971B (de) 1973-12-10
GB1338056A (en) 1973-11-21
NO133548C (de) 1976-05-19
IL36827A (en) 1974-10-22
NO133548B (de) 1976-02-09
BE768689A (fr) 1971-12-20
IE35369L (en) 1971-12-19
GB1338057A (en) 1973-11-21

Similar Documents

Publication Publication Date Title
AR204384A1 (de)
NO133548C (de)
ATA96471A (de)
HU162805B (de)
AU2044470A (de)
AU2130570A (de)
AU2017870A (de)
AU2085370A (de)
AU1833270A (de)
AR195465A1 (de)
AU2112570A (de)
AU2131570A (de)
AU1083170A (de)
AU1086670A (de)
AU1841070A (de)
AU1872870A (de)
AU1879170A (de)
AU1881070A (de)
AU1918570A (de)
AU1943370A (de)
AU1789870A (de)
AU1969370A (de)
AU1974970A (de)
ATA672271A (de)
AU2061170A (de)

Legal Events

Date Code Title Description
ST Notification of lapse